當(dāng)前位置：首頁(yè) JCRQ1 期刊介紹(非官網(wǎng))

Neurology And TherapySCIE

國(guó)際簡(jiǎn)稱(chēng)：NEUROL THER 參考譯名：神經(jīng)病學(xué)和治療

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q1

基本信息：: ISSN：2193-8253; E-ISSN：2193-6536; 是否OA：開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：SPRINGER LONDON LTD; 出版語(yǔ)言：English; 出版周期：4 issues per year; 研究方向：CLINICAL NEUROLOGY

評(píng)價(jià)信息：: 影響因子：3.9; CiteScore指數(shù)：5.4; SJR指數(shù)：1.04; SNIP指數(shù)：1.05

發(fā)文數(shù)據(jù)：: Gold OA文章占比：99.31%; 研究類(lèi)文章占比：79.25%; 年發(fā)文量：106; 自引率：0.0810...; 開(kāi)源占比：0.9872; 出版撤稿占比：0; 出版國(guó)人文章占比：0; OA被引用占比：1

投稿咨詢(xún) 加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Neurology And Therapy期刊介紹

Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

期刊簡(jiǎn)介Neurology And Therapy期刊介紹

《Neurology And Therapy》是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間： 6 Weeks
醫(yī)學(xué)
CLINICAL NEUROLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Neurology And Therapy Cite Score數(shù)據(jù)

CiteScore：5.4
SJR：1.042
SNIP：1.049

學(xué)科類(lèi)別	分區(qū)	排名	百分位
大類(lèi)：Medicine 小類(lèi)：Neurology (clinical)	Q2	134 / 400	66%
大類(lèi)：Medicine 小類(lèi)：Neurology	Q2	67 / 192	65%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Neurology And Therapy 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類(lèi)學(xué)科	分區(qū)	小類(lèi)學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類(lèi)似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書(shū)管理及圖書(shū)情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Neurology And Therapy JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CLINICAL NEUROLOGY	SCIE	Q1	54 / 277	80.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CLINICAL NEUROLOGY	SCIE	Q1	63 / 278	77.52%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門(mén)類(lèi)和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA73
England26
Italy18
GERMANY (FED REP GER)17
Canada12
Switzerland11
Brazil7
France7
Sweden7
Japan6

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral Hemorrhage
Author: Li, Jingchen; Li, Zhiyong; Zhao, Lin; Wang, Yuanyu; Yang, Jiankai; Feng, Yan; Zhang, Xiaowei; Wu, Xiuwen

Journal: NEUROLOGY AND THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40120-023-00465-w
2、Brain Complexity Predicts Response to Adrenocorticotropic Hormone in Infantile Epileptic Spasms Syndrome: A Retrospective Study
Author: Zhang, Chu-Ting; Sun, Yu-Lin; Shi, Wen-Bin; Yang, Guang; Yeh, Chien-Hung

Journal: NEUROLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 129-144. DOI: 10.1007/s40120-022-00412-1
3、Association between Serum Amyloid A Level and White Matter Hyperintensity Burden: a Cross-Sectional Analysis in Patients with Acute Ischemic Stroke
Author: Zhang, Peng; Han, Rongrong; Zhang, Aimei; Zhang, Xiaohong; Zhang, Ziheng; Yu, Hao; Li, Hongfang; Qi, Ziyou; Xu, Peng; Yang, Peng; Li, Daojing

Journal: NEUROLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 161-175. DOI: 10.1007/s40120-022-00415-y
4、Non-drug Therapies for Alzheimer's Disease: A Review
Author: Li, Xianqian; Ji, Min; Zhang, Hongmei; Liu, Zunjian; Chai, Yujing; Cheng, Qi; Yang, Yue; Cordato, Dennis; Gao, Jianqun

Journal: NEUROLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 39-72. DOI: 10.1007/s40120-022-00416-x
5、Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period
Author: Ma, Jiuhong; Fan, Xiuzhao; Cai, Xinfeng; Ji, Hongming; Li, Yuanping; Guo, Jinlin

Journal: NEUROLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 197-209. DOI: 10.1007/s40120-022-00419-8
6、Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
Author: Liang, Beibei; Wang, Jin; Zhang, Guanxuanzi; Wang, Rui; Cai, Yun

Journal: NEUROLOGY AND THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40120-023-00480-x
7、Optic Nerve Sheath Fenestration for Progressive Visual Loss in Cerebral Venous Sinus Thrombosis: A Long-Term Retrospective Observational Study
Author: Li, Zongshan; Cheng, Lu; Xu, Yang; Sun, Qiao; Zhang, Jian; Bai, Lin; Feng, Ting; Tan, Song; Wang, Huan; Deng, Bolin; Li, Qiang; Gui, Yaxing; Chen, Hui

Journal: NEUROLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 441-457. DOI: 10.1007/s40120-022-00434-9
8、The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy
Author: Feng, Yijie; Cui, Yiqin; Jin, Jianing; Huang, Siyi; Wei, Jia; Yao, Mei; Zhou, Dongming; Mao, Shanshan

Journal: NEUROLOGY AND THERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40120-023-00477-6